Adolescent Drug Abuse MDFT Case Study (Part 2 of 2)
Adolescent Drug Abuse MDFT Case Study (Part 2 of 2) – This is part two of a presentation of a typical MDFT case. To see additional videos, including part one of this case presentation, please go to our YouTube channel (www.youtube.com ), or go directly to the videos using the following links: (1) Multidimensional Family Therapy, An Introduction (Part 1 of 2) www.youtube.com (2) Multidimensional Family Therapy, An Introduction (Part 2 of 2) www.youtube.com (3) Risk and Protective Factors www.youtube.com (4) MDFT – Juvenile Justice www.youtube.com (5) Adolescent Treatment www.youtube.com (6) Adolescent Drug Abuse MDFT Case Study (Part 1 of 2) www.youtube.com (7) Adolescent Drug Abuse MDFT Case Study (Part 2 of 2) www.youtube.com (8) Future of Adolescent Treatment and Research www.youtube.com (9) Dr. Howard Liddle, Multidimensional Family Therapy DVD (APA Video Series) www.youtube.com (10) MDFT (Multidimensional Family Therapy, in Dutch with English subtitles) www.youtube.com (11) MDFT (Multidimensional Family Therapy, Dutch version) www.youtube.com (12) MDFT (Multidimensional Family Therapy, German version) www.youtube.com About Dr. Howard Liddle: Howard A. Liddle, EdD, ABPP (Family Psychology), is Professor, in the Departments of Epidemiology and Public Health and Psychology, and Director, of the Center for Treatment Research on Adolescent Drug Abuse at the University of Miami Miller School of Medicine (www.miami.edu\ctrada).Trained as a psychologist and family therapist, Dr. Liddle directs a long term program of National …
Impax Laboratories Launches Oxymorphone Hydrochloride Extended-Release …
Filed under: drug abuse treatment outcome study
The risk for opioid abuse is increased in patients with a personal or family history of substance abuse (including drug or alcohol abuse or addiction) or mental illness (e.g., major depression). Patients at increased risk may still be appropriately …
Read more on MarketWatch (press release)
Alkermes Expands CNS Pipeline and Announces Positive Results from Phase 1 …
Filed under: drug abuse treatment outcome study
Alkermes plc (NASDAQ:ALKS) today announced positive topline results from a phase 1 study of its new antipsychotic candidate, ALKS 3831, a combination of a proprietary drug molecule, ALKS 33, and olanzapine, a molecule that is commercially available …
Read more on MarketWatch (press release)
It's the Drugs, Stupid!
Filed under: drug abuse treatment outcome study
Today, many of our children are prescribed the same psychotropic drugs as were given to our soldiers, in the children's case for the treatment of such conditions as ADHD and for psychiatric disorders. In fact, the practice of … we are legal drug …
Read more on American Thinker